13.7 C
New York
Saturday, October 1, 2022

Compass Pathways Highlights Open-Label Study Of COMP360 Psilocybin Therapy For Depression In Cancer Patients; Says Study Demonstrates Feasibility Of Simultaneous Psilocybin Administration In Small Groups – Benzinga

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

12 + ten =

Stay Connected

0FansLike
3,505FollowersFollow
0SubscribersSubscribe

Latest Articles